HeimSNY • NASDAQ
add
Sanofi SA
48,28 $
Eftir lokun(0,021%)+0,010
48,29 $
Lokað: 22. nóv., 17:11:00 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
47,98 $
Dagbil
47,99 $ - 48,54 $
Árabil
45,22 $ - 58,97 $
Markaðsvirði
122,33 ma. USD
Meðalmagn
2,12 m.
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(EUR) | sep. 2024info | Breyting á/á |
---|---|---|
Tekjur | 14,16 ma. | 11,49% |
Rekstrarkostnaður | 5,99 ma. | 11,39% |
Nettótekjur | 2,82 ma. | 11,49% |
Hagnaðarhlutfall | 19,88 | -0,05% |
Hagnaður á hvern hlut | 1,54 | -39,43% |
EBITDA | 4,91 ma. | 15,96% |
Virkt skatthlutfall | 20,58% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(EUR) | sep. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 6,80 ma. | -14,99% |
Heildareignir | — | — |
Heildarskuldir | — | — |
Eigið fé alls | 73,00 ma. | — |
Útistandandi hlutabréf | 1,25 ma. | — |
Eiginfjárgengi | 0,83 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 10,54% | — |
Peningaflæði
Breyting á handbæru fé
(EUR) | sep. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 2,82 ma. | 11,49% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Framkvæmdastjóri
Stofnsett
1973
Höfuðstöðvar
Vefsvæði
Starfsfólk
86.088